UAS
United Asset Strategies’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-8,129
| Closed | -$771K | – | 246 |
|
2024
Q1 | $771K | Buy |
+8,129
| New | +$771K | 0.08% | 168 |
|
2023
Q4 | – | Sell |
-2,796
| Closed | -$204K | – | 253 |
|
2023
Q3 | $204K | Buy |
+2,796
| New | +$204K | 0.03% | 219 |
|
2022
Q1 | – | Sell |
-3,409
| Closed | -$382K | – | 241 |
|
2021
Q4 | $382K | Sell |
3,409
-3,198
| -48% | -$358K | 0.05% | 168 |
|
2021
Q3 | $831K | Buy |
6,607
+440
| +7% | +$55.3K | 0.11% | 128 |
|
2021
Q2 | $835K | Sell |
6,167
-230
| -4% | -$31.1K | 0.11% | 126 |
|
2021
Q1 | $868K | Sell |
6,397
-2,347
| -27% | -$318K | 0.13% | 117 |
|
2020
Q4 | $1.23M | Buy |
8,744
+1,056
| +14% | +$149K | 0.19% | 92 |
|
2020
Q3 | $857K | Sell |
7,688
-1,690
| -18% | -$188K | 0.16% | 102 |
|
2020
Q2 | $1.05M | Sell |
9,378
-165
| -2% | -$18.5K | 0.21% | 90 |
|
2020
Q1 | $739K | Sell |
9,543
-2,205
| -19% | -$171K | 0.18% | 100 |
|
2019
Q4 | $1.12M | Buy |
11,748
+960
| +9% | +$91.3K | 0.22% | 98 |
|
2019
Q3 | $823K | Buy |
10,788
+315
| +3% | +$24K | 0.18% | 104 |
|
2019
Q2 | $919K | Sell |
10,473
-165
| -2% | -$14.5K | 0.21% | 100 |
|
2019
Q1 | $963K | Sell |
10,638
-70
| -0.7% | -$6.34K | 0.23% | 101 |
|
2018
Q4 | $768K | Sell |
10,708
-425
| -4% | -$30.5K | 0.21% | 101 |
|
2018
Q3 | $1.07M | Sell |
11,133
-144
| -1% | -$13.8K | 0.25% | 94 |
|
2018
Q2 | $1.07M | Sell |
11,277
-420
| -4% | -$40K | 0.28% | 89 |
|
2018
Q1 | $1.03M | Sell |
11,697
-1,534
| -12% | -$135K | 0.3% | 86 |
|
2017
Q4 | $1.12M | Buy |
+13,231
| New | +$1.12M | 0.3% | 81 |
|
2017
Q3 | – | Sell |
-18,561
| Closed | -$1.43M | – | 172 |
|
2017
Q2 | $1.43M | Sell |
18,561
-43,810
| -70% | -$3.38M | 0.43% | 64 |
|
2017
Q1 | $4.33M | Buy |
+62,371
| New | +$4.33M | 1.32% | 29 |
|